NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Blocking pathogenic anti-donor antibody responses
Blocking pathogenic anti-donor antibody responses is a funding opportunity from NEW YORK UNIVERSITY SCHOOL OF MEDICINE, up to 76780, closing March 31, 2029.
Mar 31, 2029
(974d left)Overview
PROJECT SUMMARY This proposal outlines a three-year training plan focused on developing antibody-based therapies that address transplant rejection driven by donor-specific antibodies (DSAs). DSAs recognize mismatched human leukocyte antigens (HLAs) on transplanted organs, leading to antibody-mediated rejection (AMR)…